Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	590.54M +51.7%
Revenue (ttm)	438.23K -69.5%
Net Income	-37.96M
EPS	-0.12
Shares Out	320.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	626,136
Average Volume	566,098
Open	1.870
Previous Close	1.840
Day's Range	1.870 - 1.955
52-Week Range	1.115 - 2.250
Beta	0.40
RSI	43.44
Earnings Date	Apr 29, 2026

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with except...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2025, Imricor Medical Systems's revenue was $292,309, a decrease of -69.53% compared to the previous year's $959,424. Losses were -$25.32 million, -14.73% less than in 2024.

Financial numbers in USD